Otonomy, Inc. (OTIC): Price and Financial Metrics


Otonomy, Inc. (OTIC): $1.80

0.04 (+2.25%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add OTIC to Watchlist
Sign Up

Industry: Biotech


Ranked

of 505

in industry

OTIC POWR Grades


  • OTIC scores best on the Sentiment dimension, with a Sentiment rank ahead of 91.42% of US stocks.
  • OTIC's strongest trending metric is Momentum; it's been moving down over the last 48 weeks.
  • OTIC ranks lowest in Momentum; there it ranks in the 9th percentile.

OTIC Stock Summary

  • With a price/sales ratio of 462.4, Otonomy Inc has a higher such ratio than 98.7% of stocks in our set.
  • The volatility of Otonomy Inc's share price is greater than that of 98.14% US stocks with at least 200 days of trading history.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for OTIC comes in at -92.38% -- higher than that of only 2.57% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Otonomy Inc, a group of peers worth examining would be BLUE, BCDA, EVGN, CYCN, and APTX.
  • OTIC's SEC filings can be seen here. And to visit Otonomy Inc's official web site, go to www.otonomy.com.

OTIC Valuation Summary

  • In comparison to the median Healthcare stock, OTIC's price/sales ratio is 3315.86% higher, now standing at 387.7.
  • OTIC's price/earnings ratio has moved up 7.7 over the prior 86 months.
  • OTIC's EV/EBIT ratio has moved up 7.2 over the prior 86 months.

Below are key valuation metrics over time for OTIC.

Stock Date P/S P/B P/E EV/EBIT
OTIC 2021-08-31 387.7 1.1 -1.9 -0.8
OTIC 2021-08-30 360.5 1.1 -1.8 -0.6
OTIC 2021-08-27 372.8 1.1 -1.8 -0.7
OTIC 2021-08-26 365.4 1.1 -1.8 -0.7
OTIC 2021-08-25 360.5 1.1 -1.8 -0.6
OTIC 2021-08-24 354.4 1.0 -1.7 -0.6

OTIC Growth Metrics

  • Its 4 year price growth rate is now at -80.42%.
  • The year over year price growth rate now stands at -13.33%.
  • Its year over year revenue growth rate is now at -64.26%.
Over the past 52 months, OTIC's revenue has gone down $800,000.

The table below shows OTIC's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 0.228 -40.944 -46.236
2021-03-31 0.203 -39.1 -45.178
2020-12-31 0.273 -38.874 -44.731
2020-09-30 0.313 -37.885 -45.009
2020-06-30 0.388 -37.515 -44.181
2020-03-31 0.568 -38.562 -44.454

OTIC's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • OTIC has a Quality Grade of D, ranking ahead of 11.27% of graded US stocks.
  • OTIC's asset turnover comes in at 0.002 -- ranking 420th of 677 Pharmaceutical Products stocks.
  • AVDL, LNTH, and CRDF are the stocks whose asset turnover ratios are most correlated with OTIC.

The table below shows OTIC's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.002 -2.654 -0.608
2021-03-31 0.002 -4.931 -0.599
2020-12-31 0.003 -3.352 -0.598
2020-09-30 0.004 -2.802 -0.642
2020-06-30 0.005 -2.147 -0.594
2020-03-31 0.007 -0.607 -0.493

OTIC Price Target

For more insight on analysts targets of OTIC, see our OTIC price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $5.63 Average Broker Recommendation 1.4 (Strong Buy)

OTIC Stock Price Chart Interactive Chart >

Price chart for OTIC

OTIC Price/Volume Stats

Current price $1.80 52-week high $6.98
Prev. close $1.76 52-week low $1.14
Day low $1.77 Volume 9,448
Day high $1.80 Avg. volume 655,386
50-day MA $1.61 Dividend yield N/A
200-day MA $2.94 Market Cap 102.00M

Otonomy, Inc. (OTIC) Company Bio


Otonomy Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear. The company was founded in 2008 and is based in San Diego, California.


OTIC Latest News Stream


Event/Time News Detail
Loading, please wait...

OTIC Latest Social Stream


Loading social stream, please wait...

View Full OTIC Social Stream

Latest OTIC News From Around the Web

Below are the latest news stories about Otonomy Inc that investors may wish to consider to help them evaluate OTIC as an investment opportunity.

What Is The Ownership Structure Like For Otonomy, Inc. (NASDAQ:OTIC)?

If you want to know who really controls Otonomy, Inc. ( NASDAQ:OTIC ), then you'll have to look at the makeup of its...

Yahoo | September 22, 2021

Otonomy to Participate in Two Upcoming Investor Conferences

SAN DIEGO, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that management is scheduled to participate in two upcoming virtual conferences:

Intrado Digital Media | September 2, 2021

Otonomy Appoints Jill Broadfoot to Board of Directors

SAN DIEGO, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced the appointment of Jill Broadfoot to its board of directors.

Intrado Digital Media | August 19, 2021

Otonomy Reports Second Quarter 2021 Financial Results and Provides Corporate Update

Conference call and webcast today at 4:30 p.m. ET

Intrado Digital Media | August 4, 2021

Otonomy (OTIC) Reports Q2 Loss, Lags Revenue Estimates

Otonomy (OTIC) delivered earnings and revenue surprises of -11.76% and -46.15%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | August 4, 2021

Read More 'OTIC' Stories Here

OTIC Price Returns

1-mo 20.00%
3-mo -17.05%
6-mo -29.41%
1-year -50.00%
3-year -34.55%
5-year -89.46%
YTD -72.18%
2020 68.93%
2019 107.03%
2018 -66.67%
2017 -65.09%
2016 -42.70%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9008 seconds.